Details of this Paper

how should Pharma account for the restructuring program for the year ended December 31, 2011

Description

solution


Question

In reporting to its U.K. parent under IFRSs, how should Pharma account for the restructuring program for the year ended December 31, 2011?;Alternative 1 ? A restructuring plan exists as of December 31, 2011, under IFRSs. Pharma should record a provision for its restructuring plan for the year ended December 31, 2011.;Alternative 2 ? A restructuring plan does not exist as of December 31, 2011, under IFRSs. Pharma should not record a provision for its restructuring plan for the year ended December 31, 2011.;2. In reporting to its U.S.-based lender in accordance with U.S. GAAP, how should Pharma account for the restructuring program for the year ended December 31, 2011?;Alternative 1 ? A restructuring plan exists as of December 31, 2011, under U.S. GAAP. Pharma should record a provision for its restructuring plan for the year ended December 31, 2011.;Alternative 2 ? A restructuring plan does not exist as of December 31, 2011, under U.S. GAAP. Pharma should not record a provision for its restructuring plan for the year ended December 31, 2011.;The accounting issue is whether Pharma Co. should record a provision for the planned restructuring, which includes relocation of an existing manufacturing operation, for the year ended December 31, 2011. A secondary issue is what costs would be included in the restructuring provision if it is determined that a liability should be recognized at year-end. Your solution must be supported by cites from the appropriate professional literature: both IAS pronouncements and FASB Codification.

 

Paper#20757 | Written in 18-Jul-2015

Price : $32
SiteLock